Sol Capital Management CO Bristol Myers Squibb CO Transaction History

Sol Capital Management CO

$901 Million
Q3 2024

A detailed history of Sol Capital Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sol Capital Management CO holds 12,018 shares of BMY stock, worth $694,159. This represents 0.07% of its overall portfolio holdings.

Number of Shares

12,018

Previous 12,618 4.76%

Holding current value

$694,159

Previous $524,000 18.7%

% of portfolio

0.07%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$39.66 - $51.75 $23,795 - $31,050	-600 Reduced 4.76%	12,018 $622,000
Q2 2024 Jul 23, 2024	BUY	$40.25 - $52.99 $21,332 - $28,084	530 Added 4.38%	12,618 $524,000
Q4 2023 Jan 25, 2024	BUY	$48.48 - $57.85 $4,848 - $5,785	100 Added 0.83%	12,088 $620,000
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $11,578 - $12,946	-200 Reduced 1.64%	11,988 $696,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $31,855 - $35,370	-500 Reduced 3.94%	12,188 $779,000
Q1 2023 Apr 19, 2023	SELL	$65.71 - $74.53 $6,570 - $7,453	-100 Reduced 0.78%	12,688 $879,000
Q4 2022 Jan 24, 2023	SELL	$68.48 - $81.09 $9,587 - $11,352	-140 Reduced 1.08%	12,788 $0
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $24 - $14,215	-185 Reduced 1.41%	12,928 $919,000
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $52,649 - $57,985	-725 Reduced 5.24%	13,113 $1.01 Million
Q1 2022 Apr 18, 2022	SELL	$61.48 - $73.72 $52,258 - $62,662	-850 Reduced 5.79%	13,838 $1.01 Million
Q4 2021 Jan 19, 2022	SELL	$53.63 - $62.52 $10,726 - $12,504	-200 Reduced 1.34%	14,688 $916,000
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $22,188 - $25,991	-375 Reduced 2.46%	14,888 $881,000
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $18,573 - $20,226	-300 Reduced 1.93%	15,263 $1.02 Million
Q1 2021 Apr 22, 2021	SELL	$59.34 - $66.74 $65,274 - $73,414	-1,100 Reduced 6.6%	15,563 $982,000
Q4 2020 Jan 22, 2021	SELL	$57.74 - $65.43 $5,774 - $6,543	-100 Reduced 0.6%	16,663 $1.03 Million
Q3 2020 Oct 23, 2020	SELL	$57.43 - $63.64 $2,871 - $3,182	-50 Reduced 0.3%	16,763 $1.01 Million
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $767 - $897	-14 Reduced 0.08%	16,813 $989,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $32,480 - $47,201	-700 Reduced 3.99%	16,827 $938,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $3,936 - $5,135	80 Added 0.46%	17,527 $1.13 Million
Q3 2019 Oct 21, 2019	SELL	$42.77 - $50.71 $53,462 - $63,387	-1,250 Reduced 6.69%	17,447 $885,000
Q1 2019 Apr 30, 2019	SELL	$45.12 - $53.8 $15,792 - $18,830	-350 Reduced 1.84%	18,697 $892,000
Q2 2018 Jul 11, 2018	BUY	$50.53 - $62.98 $6,316 - $7,872	125 Added 0.66%	19,047 $1.05 Million
Q1 2018 Apr 25, 2018	SELL	$59.92 - $68.98 $31,937 - $36,766	-533 Reduced 2.74%	18,922 $1.2 Million
Q4 2017 Jan 31, 2018	SELL	$59.94 - $65.35 $257,742 - $281,005	-4,300 Reduced 18.1%	19,455 $1.19 Million
Q3 2017 Oct 27, 2017	BUY	$55.23 - $63.74 $1.31 Million - $1.51 Million	23,755	23,755 $1.51 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Sol Capital Management CO with notifications on news.

Account

Sol Capital Management CO Bristol Myers Squibb CO Transaction History